Why Partner?
Following a rollercoaster of investments and money flow in the cell therapy industry over the last 2 years, we are now seeing a resurgence. In just the last year we’ve seen over $700 million of funding into CAR-T therapy biopharma assets, and over $1 billion in M&A’s and 9 new approvals.
As we see this resurgence, biopharma is reliant on the educational thought leadership and support of leading vendors who can keep up with their innovative approaches.
Will you stand up and be part of the new wave of innovation coming to CAR-TCR?
Who Will You Meet?
Download Your Complete Guide to the Meeting:
What Our Audience Needs:
 Sequencing Services  Why Partner?
Establish yourself as the go to service provider for the cell therapy industry: With the increasing number of deals and investments there is an increasing need for service providers to help drug developers optimize manufacturing process and remain at the forefront of innovation
Unrivalled industry networking: Connect directly with over 250 scientific experts and decision makers in the cell therapy field who are actively seeking support. Utilise our app and badge scanning functionality to make better connections faster
Benefit from market intelligence: Hear about the latest innovations in the field directly from the drug developers to stay ahead of the curve and ensure you are meeting the industry’s growing needs
Educate your target audience: Make best use of the spotlight during your presentation to educate prospective clients about your services through data driven and case-study based presentations
Who Could You Meet?
